CRAF GENE MUTATION
Clinical trials for CRAF GENE MUTATION explained in plain language.
Never miss a new study
Get alerted when new CRAF GENE MUTATION trials appear
Sign up with your email to follow new studies for CRAF GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug trial halted early for advanced cancers
Disease control TerminatedThis early-stage trial tested an experimental drug called DCC-3084, both alone and combined with other cancer therapies, in people with advanced solid tumors driven by specific genetic mutations. The study aimed to find a safe dose and see if the drug could shrink tumors. It was …
Matched conditions: CRAF GENE MUTATION
Phase: PHASE1 • Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
First patients test new pill targeting Cancer's genetic engine
Disease control TerminatedThis first-in-human study tested a new oral drug called IK-595 in adults with advanced solid tumors that have specific genetic changes (in RAS or RAF genes) and no other treatment options. The main goals were to find a safe dose, see how the body processes the drug, and check for…
Matched conditions: CRAF GENE MUTATION
Phase: PHASE1 • Sponsor: Ikena Oncology • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC